
Barinthus Biotherapeutics plc / Financial strength (Piotroski F-Value)
The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Return on assets (ROA) greater than 0
- close -33.0%
- Operating cash flow greater than 0
- close -$32.06M
- ROA greater than previous year
- close -33.0% ≤ -22.3%
- Cash flow return on assets (CFROA) greater than Return on assets (ROA)
- check -26.5% > -33.0%
- Leverage ratio lower than previous year
- close 7.0% ≥ 4.5%
- Current ratio greater than previous year
- close 917.5% ≤ 1,525.7%
- No new common stock issued last year
- check -$1.72M
- Gross margin greater than previous year
- check 77.4% > -237.4%
- Asset turnover greater than previous year
- check 20.5% > 5.5%
F-Value history
The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.
-
4
-
3
-
3
-
5
-
3
-
4
-
1
-
1
-
1
-
4
-
4